|Articles|September 4, 2018

Use of Extractables Data from Single-Use Components for Risk Assessments

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

How Codexis is Redefining Pharma Biocatalysis

ByMandy Vink,Codexis

December 18th 2025

How Codexis is Transforming RNA Manufacturing

ByBritton Jimenez,Codexis

December 18th 2025

Gene Therapy Unlocked: Overcoming Challenges and Accelerating the Path to Patients

ByFUJIFILM Biotechnologies,Hartmut Tintrup, Executive Director, Commercial Development, FUJIFILM Biotechnologies

December 17th 2025

De-risking Biologic Development: Engineering Flexibility from Early Development to Launch

ByFUJIFILM Biotechnologies,Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies

December 17th 2025

Developing Your Biologic with Technology, Process Strategy, and Market Strategy in Mind

ByFUJIFILM Biotechnologies,Charles Heise, Associate Director, Bioprocess Strategy & Development, FUJIFILM Biotechnologies

December 17th 2025

Use of Extractables Data from Single-Use Components for Risk Assessments

Newsletter

Related Content

How Codexis is Redefining Pharma Biocatalysis

How Codexis is Transforming RNA Manufacturing

Gene Therapy Unlocked: Overcoming Challenges and Accelerating the Path to Patients

De-risking Biologic Development: Engineering Flexibility from Early Development to Launch

Developing Your Biologic with Technology, Process Strategy, and Market Strategy in Mind

Trending on Pharmaceutical Technology

Industry Outlook 2026: Trends Transitioning from 2025 into 2026

Amgen Acquires UK Biotech Dark Blue Therapeutics

Navigating Financial and Opportunity Risks in Accelerated Drug Launches

Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining

Gene Therapy, Rare Diseases, and Transfer RNA